1
play

1 Terry Moore, B.Sc., M.Sc., PhD. (abd) 24 years experience of - PowerPoint PPT Presentation

Jun 19, 2023 •364 likes •653 views

1 Terry Moore, B.Sc., M.Sc., PhD. (abd) 24 years experience of treating chronic and recurrent pain based upon discoveries during his PhD studies at the University of Guelph Worx Integrated Terry Moore developed the Myo yoWo Treatment

  1. 1

  2. Terry Moore, B.Sc., M.Sc., PhD. (abd) • 24 years experience of treating chronic and recurrent pain based upon discoveries during his PhD studies at the University of Guelph Worx  Integrated • Terry Moore developed the Myo yoWo Treatment Program • Moore’s clinic, MMTR Health Inc., is located in Guelph, Ontario. 2

  3. MMTR Health Inc. Worx  Integrated Treatment Program The Myo Wo is a muscle relaxation and restoration treatment based proprietary technology initially aimed at treating patients with chronic and recurring pain. Today, MMTR treats many referred patients with various other pathological conditions that have not responded to conventional therapies. 3

  4. MyoWorx My TM TM Integrated Treatment for Chronic and Recurring Pain orx  Treatment Program is comprised of 3 parts : The My MyoWor 1. Individual Patient Assessment 2. Muscle Relaxation/Restoration Treatment using the Proprietary TM20 muscle relaxation device. Data strongly suggest it restores function to blood vessels, muscles and nerves 3. A Tailored Exercise Program 4

  5. My MyoWorx TM TM Individual Patient Assessment  Detailed focused history  Examination of symptom areas  Identifies need for ancillary laboratory tests  Assessment of contributory factors 5

  6. My MyoWorx TM TM Treatment Rationale Increased tension, painful spasm, fatigue or injury of the muscles supporting the spine can cause pressure on the spinal nerves as well as other paraspinal tissues and structures. As a result, one can experience: • pain, tingling or numbness • altered functioning of muscles • secondary effects on organs Unresolved, numerous muscle and joint injuries, chronic or recurring pain and neurological and other physical symptoms can perpetuate 6

  7. My MyoWorx TM TM TM20 Device How it works  A patented device that delivers a sequence of electrical frequencies in a timed manner to the paraspinal structures.  Pre-clinical studies showed these frequencies can: • Re-establish normal resting membrane potentials in the cells of fatigued or injured muscles • Evoke CNS activity that facilitates muscle relaxation; long-term effect • Produce increases in blood flow via smooth muscle relaxation leading to restoration of oxygen and nutrient uptake 7

  8. My MyoWorx TM TM TM20 Device Results in improvement of:  Muscle function • Better ability to stretch and maintain optimal muscle fiber length resulting in increased muscle strength and endurance  Blood flow • Breaks the cycle of vasoconstriction • Increases vascular perfusion Cannot be achieved by stretching and strengthening exercises alone 8

  9. MyoWorx  TM20 Device My FDA Approved as a ‘Electronic Muscle Exerciser’: April 1982 Labeling as follows: 1. Relaxation of muscle spasm 2. Prevention of retardation of tissue atrophy 3. Increasing local blood circulation 4. Muscle-re-education 5. Immediate postsurgical stimulation of calf muscles to prevent venous thrombosis 6. Maintaining of increasing range of motion 9

  10. MyoWorx  TM2 My TM20 De Devic ice Why is the TM20 different from?  Transcutaneous Electrical Nerve Stimulation (TENS), Interferential Current (IFC), or Muscle Stimulation • TENS/IFC manage pain via direct nerve stimulation • Increase blood flow and muscle relaxation through varying degrees of electrically-induced muscle contraction - usually a short term effect  TM20 patented technology aims directly at reducing the underlying muscle spasm and relieves the associated pathologies of both neurological and micro-vasculature structures - potentially long term sustainable results 10

  11. MyoWorx My TM Targeted Exercise and Symptom Management Strategies  Moderate home-based stretching and strengthening exercises aimed at ‘re-educating’ the musculature  Essential to providing long-term benefit  Educates and empowers the patient to manage symptoms • Reduces emotional impact • Creates awareness of external factors e.g., barometric pressure effects 11

  12. TM Pro My MyoWorx rogra ram Clinical Data on Chronic and Recurring Pain 12

  13. TM Program MyoWorx My am Clinical Dat Data a on on Chr hroni onic and and Recur urring Pai ain  Consecutive patients treated over a 10 year period  Data analysis Group: N=518 including 32 patients with associated anxiety and/ or depression  All patients received the MyoWorx  treatment program  MMTR recorded additional outcomes to determine the effects of the MyoWorx  Muscle Relaxation/Restoration Treatment and Targeted Exercise on associated conditions 13

  14. TM Pro My MyoWorx rogra ram Clinical Dat Data a on on Chr hroni onic and and Recur urring Pai ain Patient Characteristics  All patients presented with chronic and recurring pain many of whom, in retrospect, had referred pain syndromes  Presentation of pain: arthritis, migraine headaches, motor vehicle accidents, occupational origins including repetitive strain injuries  Pain location: head, trunk and limbs  Prior therapies included: medications, nerve block, traditional physiotherapy, TENS, acupuncture, chiropractic, and registered massage therapy 14

  15. TM Pro MyoWorx My rogra ram Clinical Dat Data a on on Chr hroni onic and and Recur urring Pai ain Methodology  The degree of pain in all patients was assessed using the Borg Pain Scale (0 to 10; 10 being most severe)  Patients pain levels were recorded before and after each treatment  Symptoms of tingling or numbness were also graded on a similar scale  Anatomical location of pain, anaesthesia or paraesthesia were categorized as cervical, trapezius, thoracic, lumbar and sacral 15

  16. TM Pro My MyoWorx rogra ram Clinical Dat Data a on on Chr hroni onic and and Recur urring Pai ain Methodology ( continued )  Results were grouped as percent reduction in overall pain score: Category % Reduction in Pain Level Poor 0-30% Moderate 30-70% Excellent > 70% 16

  17. TM Pro My MyoWorx rogra ram Clinical Dat Data a on on Chr hroni onic and and Recur urring Pai ain Pain Response by Anatomical Site (does not include response of referred pain syndromes) Anatomical Site Percentage Sustained Reduction in Pain Score Overall No Diagnosed Associated Depression Response Psychological Disorder or Anxiety Disorder (n=518) (n= 486) (n=32) Cervical 76% 80% 0% Trapezius 76% 81% 0% Thoracic 79% 85% 0% Lumbar 80% 85% 0% Sacral 78% 83% 0% 17

  18. TM Pro My MyoWorx rogra ram Clinical Dat Data a on on Chr hroni onic and and Recur urring Pai ain Response Rates  When there was an associated referred pain syndrome (most cases), this symptom was abolished in over 90% of instances  When the response of the associated referred pain syndrome is included in the total response rate, the percentages of responders increased. For example, a patient presenting with sciatica may experience complete resolution of associated pain in the lumber, hip, hamstring, knee and calf areas. Anatomical Site Referred Pre- Post- % reduction in pain Pain Sites treatment treatment Sciatica/ Lumbar 4 1 75% Hip 8 0 100% Hamstring 8 0 100% Knee 8 0 100% Calf 8 0 100% 95% (overall) 18

  19. Total Responders: Males vs. Females Poor Moderate Excellent 100% 91.6% 90.2% 88.0% 90% Successful Recovery 80% 70% 60% 50% 40% 30% 20% 9.5% 5.1% 6.9% 10% 3.4% 2.9% 2.3% 0% Total (n = 518) Male (n = 222) Female ( n = 296) 19

  20. Total Responders: Acute vs. Chronic Poor Moderate Excellent 100% 93.1% 88.8% Successful Recovery 90% 80% 70% 60% 50% 40% 30% 20% 7.8% 5.0% 10% 3.4% 1.9% 0% Acute (n = 160) Chronic (n = 358) 20

  21. Previous vs. No Previous Therapy Poor Moderate excellent 100% 90.0% 90.0% Successful Recovery 90% 80% 70% 60% 50% 40% 30% 20% 7.6% 6.5% 10% 3.3% 2.4% 0% Prev Ther (n = 307) No Prev Ther (n=211) 21

  22. Occupational Recovery Poor Moderate Excellent 120% 100.0% Successful Recovery 100% 92.5% 92.7% 90.2% 90.1% 89.7% 80% 60% 40% 20% 6.7% 9.2% 8.3% 0.0% 7.0% 5.0% 3.0% 2.5% 2.3% 1.1% 0.0% 0.0% 0% Occ Occ Female Occ Male Occ Lin Occ Blount Occ GGH (n=167) (n=80) (n=87) (n=128) (n=9) (n=12) 22

  23. Age and Recovery Poor Moderate Excellent 120% 100% 100% 92.1% 92.3% 90.4% 88.5% 86.0% 83.3% 80% 60% 40% 16.7% 6.90% 20% 6.90% 7.40% 5.50% 0% 5.60% 6.9% 4.6% 2.2% 2.2% 2.2% 0% 0.0% 0% 10-19 20-29 30-31 40-49 50-59 60-69 70+ (n=14) (n=89) (n=131) (n=135) (n=91) (n=29) (n = 18) 23

  24. TM Program MyoWorx My am Clinical Results on Chronic and Recurring Pain Key Findings  The My MyoWo Worx  program has a high success rate in relieving acute and chronic pain of multiple origins  All age groups benefit from treatment  Outcome is not dependent on prior therapy 24

  25. TM Program My MyoWorx am Clinical Results on Chronic and Recurring Pain Therapy had a Major Effect on Work Disability  After treatment, absenteeism and work disability due to pain were reduced for at least 6 months  Patients with low back injuries and repetitive strain injuries: • treated promptly were able to continue working ( e.g., Carpal Tunnel Syndrome) • if on disability were able to return to work soon after initiating therapy  In all responders the pain was durably reduced for at least 2 months 25

Recommend

More recommend